Organogenesis Holdings Inc. (ORGO): Cost of Revenue
$115.74M
Year ended 2024-12-31
+0.4%
3-year compound annual growth
+8.8%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $115.74M | +8.7% | 2025-02-27, From 2024-01-01 |
| 2023-12-31 | $106.48M | +1.4% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $105.02M | -8.0% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $114.20M | +30.8% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $87.32M | +15.0% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $75.95M | +10.4% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $68.81M | +12.4% | 2021-03-16, From 2018-01-01 |
| 2017-12-31 | $61.22M | +27.0% | 2020-03-09, From 2017-01-01 |
| 2016-12-31 | $48.20M | n/a | 2019-03-18, From 2016-01-01 |